(No ratings)
Dr. Holly Kai Breeden, MD is a hepatologist in Austin, TX specializing in hepatology (liver disease) and pediatric gastroenterology. She graduated from University of Nevada School of Medicine in 2018 and has 8 years of experience. Dr. Holly Kai Breeden, MD is affiliated with Baylor College of Medicine and Texas Children's.
Dr. Holly Kai Breeden, MD graduated from University of Nevada School of Medicine in 2018. She completed residency at University of Florida Health Science Center and Affiliated Hospitals. She has a state license in Texas.
Medical School: University of Nevada School of Medicine (2018)
Residency: University of Florida Health Science Center and Affiliated Hospitals (2021)
Licensed In: Texas
Dr. Holly Kai Breeden, MD is associated with these hospitals and organizations:
Dr. Holly Kai Breeden, MD does not have any reviews yet, be the first to leave a review of Dr. Holly Kai Breeden, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Holly Kai Breeden, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| ALCRESTA THERAPEUTICS, INC. |
$158
RELIZORB $158 |
|||||
|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. |
$118
Livmarli $118 |
|||||
| GENZYME CORPORATION |
$113
DUPIXENT $113 |
|||||
| Regeneron Healthcare Solutions, Inc. |
$73
DUPIXENT $73 |
|||||
| Travere Therapeutics, Inc. |
$71
Cholbam $46 |
$25 |
||||
| Other |
$214
Bylvay $68 |
LINZESS $66 |
CUVRIOR $23 |
GATTEX $20 |
Strensiq $19 |
Other $18 |
| Food and Beverage | $746 |
|---|
Dr. Holly Breeden specializes in pediatric gastroenterology and hepatology (liver disease). Her areas of clinical interest consist of inflammatory bowel disease and esophagus problems. Dr. Breeden attended the University of Nevada School of Medicine and subsequently trained at a hospital affiliated with the University of Florida Health Science Center for residency. She is affiliated with Texas Children's and Baylor College of Medicine.